Hikma Pharmaceuticals PLC
(LSE:HIK)
£
18.31
0.3 (1.67%)
Market Cap: 4.06 Bil
Enterprise Value: 4.80 Bil
PE Ratio: 27.57
PB Ratio: 2.36
GF Score: 90/100 Half Year 2021 Hikma Pharmaceuticals PLC Earnings Presentation - Pre-Recorded Transcript
Aug 06, 2021 / 07:00AM GMT
Release Date Price:
£24.55
(-7.08%)
Sigurdur Oli Olafsson
Hikma Pharmaceuticals PLC - CEO & Executive Director
Presentation - Pre-Recorded
Aug 06, 2021 / 07:00AM GMT
=====================
Corporate Participants
=====================
* Khalid Waleed Hosny Al Nabilsi
Hikma Pharmaceuticals PLC - CFO
* Sigurdur Oli Olafsson
Hikma Pharmaceuticals PLC - CEO & Executive Director
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot